This article is more than 5 years old. Information may no longer be current.

KD Pharma invests in PRN

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

KD Pharma Group is partnering with Nutriceutical Holdings, parent company of Physician Recommended Nutriceuticals, by investing in the company, becoming the largest shareholder with options to acquire the entire company.

Both companies are leading producers of omega-3 supplements, according to a press release from Physician Recommended Nutriceuticals (PRN).

“We believe we have found the ideal partner in KD [Pharma]. They are committed to growing the [Nutriceutical Holdings] companies by providing us with supply chain certainty and superior omega-3 manufacturing technology that can help us excel within a competitive omega-3 landscape,” Ken Krieg, CEO of PRN, said in the release.

“We are extremely excited to be partnering with a fast-growing company that shares our passion for product excellence,” Oscar Groet, CEO of KD Pharma, said in the release.